Uzel I, Ozguroglu M, Uzel B, Kaynak K, Demirhan O, Akman C, Oz F, Yaman M
Department of Pulmonary Diseases, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey.
Urology. 2005 Jul;66(1):195. doi: 10.1016/j.urology.2005.01.038.
We describe a 39-year-old male patient who developed bleomycin-induced pneumonitis 2 years after completion of chemotherapy for nonseminomatous testicular cancer. Bleomycin sometimes causes fatal pulmonary toxicity, including bleomycin-induced pneumonitis. The central event in the development of pneumonitis is endothelial damage of the lung vasculature due to bleomycin-induced cytokines and free radicals. Pulmonary toxicity usually begins at bleomycin administration. The development of bleomycin-induced pneumonitis up to 6 months after bleomycin therapy has also been reported. We report a patient who developed bleomycin-induced pneumonitis 2 years after the initiation of bleomycin-containing chemotherapy regimens.
我们描述了一名39岁的男性患者,他在完成非精原细胞瘤性睾丸癌化疗2年后发生了博来霉素诱导的肺炎。博来霉素有时会导致致命的肺部毒性,包括博来霉素诱导的肺炎。肺炎发生的核心事件是由于博来霉素诱导的细胞因子和自由基导致肺血管内皮损伤。肺部毒性通常在使用博来霉素时开始。也有报道称在博来霉素治疗后长达6个月发生博来霉素诱导的肺炎。我们报告了一名在含博来霉素化疗方案开始2年后发生博来霉素诱导的肺炎的患者。